(Q40632082)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7924827 AND SRC:MED&resulttype=core&format=json

28 October 2019

review article

1 reference

title

Nicotinamide treatment in the prevention of insulin-dependent diabetes mellitus (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7924827 AND SRC:MED&resulttype=core&format=json

28 October 2019

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7924827 AND SRC:MED&resulttype=core&format=json

28 October 2019

Flemming Pociot

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7924827 AND SRC:MED&resulttype=core&format=json

28 October 2019

author name string

Mandrup-Poulsen T

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7924827 AND SRC:MED&resulttype=core&format=json

28 October 2019

Reimers JI

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7924827 AND SRC:MED&resulttype=core&format=json

28 October 2019

Karlsen AE

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7924827 AND SRC:MED&resulttype=core&format=json

28 October 2019

Bjerre U

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7924827 AND SRC:MED&resulttype=core&format=json

28 October 2019

Nerup J

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7924827 AND SRC:MED&resulttype=core&format=json

28 October 2019

language of work or name

1 reference

1 December 1993

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7924827 AND SRC:MED&resulttype=core&format=json

Diabetes/metabolism reviews

28 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7924827 AND SRC:MED&resulttype=core&format=json

28 October 2019

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7924827 AND SRC:MED&resulttype=core&format=json

28 October 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7924827 AND SRC:MED&resulttype=core&format=json

28 October 2019

page(s)

295-309

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7924827 AND SRC:MED&resulttype=core&format=json

Non-genetic factors causing type 1 diabetes

28 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1002/DMR.5610090410

7 January 2021

Pathologic anatomy of the pancreas in juvenile diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002/DMR.5610090410

7 January 2021

Progression to diabetes in nonobese diabetic (NOD) mice with transgenic T cell receptors

1 reference

https://api.crossref.org/works/10.1002/DMR.5610090410

7 January 2021

Transfer of diabetes in mice prevented by blockade of adhesion-promoting receptor on macrophages

1 reference

https://api.crossref.org/works/10.1002/DMR.5610090410

7 January 2021

CD8 T cells are not required for islet destruction induced by a CD4 islet-specific T-cell clone

1 reference

https://api.crossref.org/works/10.1002/DMR.5610090410

7 January 2021

Descriptive and mechanistic considerations of interleukin 1 and insulin secretion

1 reference

https://api.crossref.org/works/10.1002/DMR.5610090410

7 January 2021

Cytokines as immune effector molecules in autoimmune endocrine diseases with special reference to insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002/DMR.5610090410

7 January 2021

Biochemical and Molecular Actions of Interleukin-1 on Pancreatic β-Cells

1 reference

https://api.crossref.org/works/10.1002/DMR.5610090410

7 January 2021

Inhibition of insulin secretion by interleukin-1 beta and tumour necrosis factor-alpha via an L-arginine-dependent nitric oxide generating mechanism

1 reference

https://api.crossref.org/works/10.1002/DMR.5610090410

7 January 2021

Interleukin-lβ-Induced Nitric Oxide Production in Isolated Rat Pancreatic Islets Requires Gene Transcription and May Lead to Inhibition of the Krebs Cycle Enzyme Aconitase*

1 reference

https://api.crossref.org/works/10.1002/DMR.5610090410

7 January 2021

Interleukin-1 beta induces the expression of an isoform of nitric oxide synthase in insulin-producing cells, which is similar to that observed in activated macrophages

1 reference

https://api.crossref.org/works/10.1002/DMR.5610090410

7 January 2021

Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction

1 reference

https://api.crossref.org/works/10.1002/DMR.5610090410

7 January 2021

Interleukin 1 beta induces the formation of nitric oxide by beta-cells purified from rodent islets of Langerhans. Evidence for the beta-cell as a source and site of action of nitric oxide

1 reference

https://api.crossref.org/works/10.1002/DMR.5610090410

7 January 2021

Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide

1 reference

https://api.crossref.org/works/10.1002/DMR.5610090410

7 January 2021

Poly (ADP-Ribose) and ADP-Ribosylation of Proteins

1 reference

https://api.crossref.org/works/10.1002/DMR.5610090410

7 January 2021

What are the types and cellular sources of free radicals in the pathogenesis of type 1 (insulin-dependent) diabetes mellitus?

1 reference

https://api.crossref.org/works/10.1002/DMR.5610090410

7 January 2021

Cyclosporin increases the rate and length of remissions in insulin-dependent diabetes of recent onset. Results of a multicentre double-blind trial.

1 reference

https://api.crossref.org/works/10.1002/DMR.5610090410

7 January 2021

Can we really predict IDDM?

1 reference

https://api.crossref.org/works/10.1002/DMR.5610090410

7 January 2021

Reactions to niacinamide

1 reference

https://api.crossref.org/works/10.1002/DMR.5610090410

7 January 2021

Lack of Carcinogenicity of Nicotinamide and Isonicotinamide following Lifelong Administration to Mice

1 reference

https://api.crossref.org/works/10.1002/DMR.5610090410

7 January 2021

Pancreatic islet cell tumors produced by the combined action of streptozotocin and nicotinamide

1 reference

https://api.crossref.org/works/10.1002/DMR.5610090410

7 January 2021

Pancreatic islet cell tumors found in rats given alloxan and nicotinamide

1 reference

https://api.crossref.org/works/10.1002/DMR.5610090410

7 January 2021

Influence of diabetes on susceptibility to experimental pancreatic cancer.

1 reference

https://api.crossref.org/works/10.1002/DMR.5610090410

7 January 2021

Effect of streptozotocin on glucose-induced insulin secretion by isolated islets of Langerhans

1 reference

https://api.crossref.org/works/10.1002/DMR.5610090410

7 January 2021

Nicotinamide Modulation of Rat Pancreatic Islet Cell Responsiveness In Vitro

1 reference

https://api.crossref.org/works/10.1002/DMR.5610090410

7 January 2021

Long-term effects of exposure of pancreatic islets to nicotinamide in vitro on DNA synthesis, metabolism and B-cell function

1 reference

https://api.crossref.org/works/10.1002/DMR.5610090410

7 January 2021

Macrophage cytotoxicity towards isolated rat islet cells: neither lysis nor its protection by nicotinamide are Beta-cell specific

1 reference

https://api.crossref.org/works/10.1002/DMR.5610090410

7 January 2021

Nicotinamide and dexamethasone inhibit interleukin-1-induced nitric oxide production by RINm5F cells without decreasing messenger ribonucleic acid expression for nitric oxide synthase

1 reference

https://api.crossref.org/works/10.1002/DMR.5610090410

7 January 2021

Nicotinamide partially reverses the interleukin-1 beta inhibition of glucose-induced insulin release in pancreatic islets

1 reference

https://api.crossref.org/works/10.1002/DMR.5610090410

7 January 2021

Islet cell DNA is a target of inflammatory attack by nitric oxide

1 reference

https://api.crossref.org/works/10.1002/DMR.5610090410

7 January 2021

Inhibition of cytokine-induced MHC class II but not class I molecule expression on mouse islet cells by niacinamide and 3-aminobenzamide

1 reference

https://api.crossref.org/works/10.1002/DMR.5610090410

7 January 2021

Nicotinamide and 3-aminobenzamide inhibit recombinant human interferon-gamma-induced HLA-DR antigen expression, but not HLA-A, B, C antigen expression, on cultured human thyroid cells

1 reference

https://api.crossref.org/works/10.1002/DMR.5610090410

7 January 2021

Animal models of diabetes.

1 reference

https://api.crossref.org/works/10.1002/DMR.5610090410

7 January 2021

Regulation of proinsulin synthesis in pancreatic islets and a new aspect to insulin-dependent diabetes

1 reference

https://api.crossref.org/works/10.1002/DMR.5610090410

7 January 2021

Mechanisms of streptozotocin- and alloxan-induced damage in rat B cells

1 reference

https://api.crossref.org/works/10.1002/DMR.5610090410

7 January 2021

Mechanisms of nicotinamide and thymidine protection from alloxan and streptozocin toxicity

1 reference

https://api.crossref.org/works/10.1002/DMR.5610090410

7 January 2021

Protective effect of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase, against streptozotocin-induced diabetes

1 reference

https://api.crossref.org/works/10.1002/DMR.5610090410

7 January 2021

Insulinopenic diabetes after rodenticide (Vacor) ingestion: a unique model of acquired diabetes in man

1 reference

https://api.crossref.org/works/10.1002/DMR.5610090410

7 January 2021

Cytotoxic effects of streptozotocin and N-nitrosomethylurea on the pancreatic B cells with special regard to the role of nicotinamide-adenine dinucleotide

1 reference

https://api.crossref.org/works/10.1002/DMR.5610090410

7 January 2021

Oxygen radicals generated by the enzyme xanthine oxidase lyse rat pancreatic islet cells in vitro

1 reference

https://api.crossref.org/works/10.1002/DMR.5610090410

7 January 2021

Studies on the ability of compounds to block the diabetogenic activity of streptozotocin.

1 reference

https://api.crossref.org/works/10.1002/DMR.5610090410

7 January 2021

Influence of nicotinamide and pyridine nucleotides on streptozotocin and alloxan-induced pancreatic B cell cytotoxicity

1 reference

https://api.crossref.org/works/10.1002/DMR.5610090410

7 January 2021

Streptozotocin diabetes in monkeys and dogs, and its prevention by nicotinamide.

1 reference

https://api.crossref.org/works/10.1002/DMR.5610090410

7 January 2021

Amelioration of Diabetes Mellitus in Partially Depancreatized Rats by Poly(ADP-ribose) Synthetase Inhibitors: Evidence of Islet B-Cell Regeneration

1 reference

https://api.crossref.org/works/10.1002/DMR.5610090410

7 January 2021

Effect of niacin/nicotinamide deficiency on the diabetogenic effect of streptozotocin

1 reference

https://api.crossref.org/works/10.1002/DMR.5610090410

7 January 2021

Studies of streptozotocin-induced insulitis and diabetes

1 reference

https://api.crossref.org/works/10.1002/DMR.5610090410

7 January 2021

Preventive and Therapeutic Effects of Large-Dose Nicotinamide Injections on Diabetes Associated with Insulitis: An Observation in Nonobese Diabetic (NOD) Mice

1 reference

https://api.crossref.org/works/10.1002/DMR.5610090410

7 January 2021

Combined treatment with nicotinamide and desferrioxamine prevents islet allograft destruction in NOD mice

1 reference

https://api.crossref.org/works/10.1002/DMR.5610090410

7 January 2021

Hormonal and environmental factors in the pathogenesis of BB rat diabetes

1 reference

https://api.crossref.org/works/10.1002/DMR.5610090410

7 January 2021

High dose nicotinamide fails to prevent diabetes in BB rats

1 reference

https://api.crossref.org/works/10.1002/DMR.5610090410

7 January 2021

Nicotinamide may extend remission phase in insulin-dependent diabetes

1 reference

https://api.crossref.org/works/10.1002/DMR.5610090410

7 January 2021

Effect of nicotinamide therapy upon B-cell function in newly diagnosed type 1 (insulin-dependent) diabetic patients

1 reference

https://api.crossref.org/works/10.1002/DMR.5610090410

7 January 2021

Effect of nicotinamide treatment on the residual insulin secretion in type 1 (insulin-dependent) diabetic patients

1 reference

https://api.crossref.org/works/10.1002/DMR.5610090410

7 January 2021

Nicotinamide increases C-peptide secretion in patients with recent onset type 1 diabetes

1 reference

https://api.crossref.org/works/10.1002/DMR.5610090410

7 January 2021

A trial of nicotinamide in newly diagnosed patients with type 1 (insulin-dependent) diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002/DMR.5610090410

7 January 2021

Double-blind randomized trial of nicotinamide on early-onset diabetes

1 reference

https://api.crossref.org/works/10.1002/DMR.5610090410

7 January 2021

Pilot trial to prevent type I diabetes: progression to overt IDDM despite oral nicotinamide

1 reference

https://api.crossref.org/works/10.1002/DMR.5610090410

7 January 2021

Prevention or delay of Type 1 (insulin-dependent) diabetes mellitus in children using nicotinamide

1 reference

https://api.crossref.org/works/10.1002/DMR.5610090410

7 January 2021

Identifiers

DOI

10.1002/DMR.5610090410

0 references

1 reference